California's Varian Medical Systems authorizes a share buyback program of up to $6 million in common stock.
Palo Alto, Calif.-based Varian Medical (NYSE:VAR) announced today the authorization of a $6 million common stock buyback program, authorized by its board of directors.
Accuray shares are up today after the medical device company reports reduced losses and increased profit margins.
Accuray (NSDQ:ARAY) shares gained nearly 10% this morning after the medical device company reported lower fiscal 1st-quarter losses and an improved profit margin.
Sunnyvale, Calif.-based Accuray logged losses of $15.5 million, or -21¢ per share, on sales of $76.6 million for the 3 months ended Sept. 30, for a loss reduction of 35.6% on a sales decline of 7.4%.
Women's health company Hologic releases final results from the 7-year MammoSite registry of breast cancer patients treated with breast brachytherapy.
Cancer-treatment devices maker Elekta's $25 million Chinese order is its largest to date.
The U.K.'s NHS Supply Chain orders 20 TrueBeam radiosurgery systems from Varian Medical Systems, doubling last year’s order.
The British NHS Supply Chain bought 20 of Varian Medical Systems' (NYSE:VAR) TrueBeam devices as part of a planned upgrade of radiotherapy and radiosurgery systems in the nation's hospitals.
Radiosurgery systems maker Accuray gains more than 10% after releasing its 4th quarter earnings report.
Wall Street piled favor on California radiosurgery systems maker Accuray (NSDQ:ARAY) after the company narrowed losses in its 4th quarter, even as sales dropped by more than 15%.
Rival radiological device makers Elekta and Varian Medical settle a lawsuit accusing the Swedish company of poaching sales reps and trade secrets from Varian.